A systematic review of lung clearance index in non-cystic fibrosis, non-primary ciliary dyskinesia bronchiectasis. (September 2022)
- Record Type:
- Journal Article
- Title:
- A systematic review of lung clearance index in non-cystic fibrosis, non-primary ciliary dyskinesia bronchiectasis. (September 2022)
- Main Title:
- A systematic review of lung clearance index in non-cystic fibrosis, non-primary ciliary dyskinesia bronchiectasis
- Authors:
- Hine, Christopher
Desai, Maya
Davies, Jane
Sapey, Elizabeth
Nagakumar, Prasad - Abstract:
- Abstract: Background: Non cystic fibrosis, non primary ciliary dyskinesia bronchiectasis (nCFnPCD-BE) results in significant morbidity with few evidence-based treatments. Objective: assessments are required to assess severity and evaluate treatment. Lung clearance index (LCI) measures ventilation inhomogeneity and is a sensitive test of disease in CF; its use in nCFnPCD-BE is unclear. Methods: A systematic review of LCI in nCFnPCD-BE was performed using standard methodology (protocol registered on PROSPERO, University of York). Results: Of 276 records identified, 12 articles, describing 519 adult and paediatric patients in cross-sectional studies were included, addressing several domains. 1: What is the utility of LCI in detecting disease and severity? LCI detected disease in adults, differentiating bronchiectasis from controls (AUC 0.90 to 0.96) and mild from moderate/severe bronchiectasis on CT (AUC 0.73). 2: Does LCI correlate with spirometry and imaging? LCI correlated with spirometry in adult (r = −0.37 to −0.61) and paediatric (r = −0.6) groups, signs of bronchiectasis on CT, and CT scoring systems (modified Reiff). 3: Does LCI relate to subjective scores of severity? In adults, LCI correlated with St. George's Respiratory Questionnaire (r = 0.18) and Bronchiectasis Severity Index (r = 0.45). 4: Does LCI identify response to intervention? LCI did not change in studies examining LCI pre-post intervention (adults treated for exacerbation and undergoing physiotherapy).Abstract: Background: Non cystic fibrosis, non primary ciliary dyskinesia bronchiectasis (nCFnPCD-BE) results in significant morbidity with few evidence-based treatments. Objective: assessments are required to assess severity and evaluate treatment. Lung clearance index (LCI) measures ventilation inhomogeneity and is a sensitive test of disease in CF; its use in nCFnPCD-BE is unclear. Methods: A systematic review of LCI in nCFnPCD-BE was performed using standard methodology (protocol registered on PROSPERO, University of York). Results: Of 276 records identified, 12 articles, describing 519 adult and paediatric patients in cross-sectional studies were included, addressing several domains. 1: What is the utility of LCI in detecting disease and severity? LCI detected disease in adults, differentiating bronchiectasis from controls (AUC 0.90 to 0.96) and mild from moderate/severe bronchiectasis on CT (AUC 0.73). 2: Does LCI correlate with spirometry and imaging? LCI correlated with spirometry in adult (r = −0.37 to −0.61) and paediatric (r = −0.6) groups, signs of bronchiectasis on CT, and CT scoring systems (modified Reiff). 3: Does LCI relate to subjective scores of severity? In adults, LCI correlated with St. George's Respiratory Questionnaire (r = 0.18) and Bronchiectasis Severity Index (r = 0.45). 4: Does LCI identify response to intervention? LCI did not change in studies examining LCI pre-post intervention (adults treated for exacerbation and undergoing physiotherapy). Overall study quality was variable. Conclusion: Contrary to data in CF, the review did not identify good quality studies defining the role of LCI in children with bronchiectasis. In adults, LCI was a sensitive measure of disease severity and correlated with clinical assessment tools. Highlights: The review summarises studies evaluating LCI in non-CF, non-PCD bronchiectasis . No good quality studies were identified evaluating the role of LCI in children with bronchiectasis . In adults, LCI was a sensitive tool to measure disease severity . In adults, LCI also correlated with several clinical assessment tools . … (more)
- Is Part Of:
- Respiratory medicine. Volume 201(2022)
- Journal:
- Respiratory medicine
- Issue:
- Volume 201(2022)
- Issue Display:
- Volume 201, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 201
- Issue:
- 2022
- Issue Sort Value:
- 2022-0201-2022-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-09
- Subjects:
- Bronchiectasis -- Lung clearance index -- Outcome measure
Chest -- Diseases -- Periodicals
Chest -- Diseases -- Great Britain -- Periodicals
Respiratory organs -- Diseases -- Periodicals
Respiratory Tract Diseases -- Periodicals
Appareil respiratoire -- Maladies -- Périodiques
Thorax -- Maladies -- Périodiques
Appareil respiratoire -- Maladies -- Traitement -- Périodiques
Electronic journals
616.2 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09546111 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09546111 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09546111 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.rmed.2022.106937 ↗
- Languages:
- English
- ISSNs:
- 0954-6111
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 7777.661900
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 23351.xml